Published in Nephron on January 01, 1989
Contribution of myo-inositol and melatonin to human reproduction. Eur J Obstet Gynecol Reprod Biol (2011) 0.91
The Combined therapy myo-inositol plus D-Chiro-inositol, in a physiological ratio, reduces the cardiovascular risk by improving the lipid profile in PCOS patients. Eur Rev Med Pharmacol Sci (2013) 0.89
Clustering of albumin excretion rate abnormalities in Caucasian patients with NIDDM. The Italian NIDDM Nephropathy Study Group. Diabetologia (1997) 0.88
Computed tomography study of pineal calcification in schizophrenia. Eur Psychiatry (1999) 0.87
Blood-lead levels in patients with chronic liver diseases. Int Arch Occup Environ Health (1983) 0.83
Acute amino acids supplementation enhances pituitary responsiveness in athletes. Med Sci Sports Exerc (1999) 0.82
Acute effect of physical exercise on serum insulin-like growth factor-binding protein 2 and 3 in healthy men: role of exercise-linked growth hormone secretion. Int J Sports Med (2001) 0.77
Estimation of statistical moments for desferrioxamine and its iron and aluminum chelates: contribution to optimisation of therapy in uremic patients. Nephron (1996) 0.76
[Italian Registry of Dialysis and Transplantation: 1996-2001 experience]. G Ital Nefrol (2004) 0.76
Role of seminal prostaglandins in male fertility. II. Effects of prostaglandin synthesis inhibition on spermatogenesis in man. J Endocrinol Invest (1985) 0.75
Pros and cons of the hyperfiltration theory in human renal transplantation. Transplantation (1995) 0.75
Moguisteine: a novel peripheral non-narcotic antitussive drug. Br J Pharmacol (1994) 0.75
Left ventricular morphology and diastolic function in uraemia: echocardiographic evidence of a specific cardiomyopathy. Br Heart J (1995) 0.75
Reduction in urinary prostaglandin excretion in the premenstrual syndrome. J Reprod Med (1993) 0.75
[Lead exposure in the adult population non-occupationally exposed]. G Ital Med Lav (1983) 0.75
Interaction between alpha-interferon and erythropoietin in antiviral and antineoplastic therapy in uraemic patients on haemodialysis. Nephrol Dial Transplant (1993) 0.75
Evidence for a cutoff value of desferrioxamine infusion test for bone aluminium deposits in hemodialyzed patients. Nephron (1986) 0.75
[The combination of minoxidil, a beta-blocking agent, and a diuretic in the therapy of refractory hypertension]. G Clin Med (1982) 0.75
[Radionephrographic documentation of a transitory renal damage due to aortography in hypertensive patients. Preventive efficacy of mannitol]. Minerva Med (1965) 0.75
[Hemodialysis in aged patients. Clinical aspects and complications]. Minerva Nefrol (1976) 0.75
[Recent progress in the technic of periodic hemodialysis]. Minerva Med (1965) 0.75
[Indications and technic for regional heparinization during hemodialysis]. Minerva Med (1967) 0.75
[Comparison between the Italian situation and that of the countries of the European Economic Community based on the lead blood levels found in the fulfillment of the European Economic Community's directive 77/312]. Ann Ist Super Sanita (1985) 0.75
Underfeeding and exposure to short photoperiod alters rat pineal and Harderian gland lysosomal enzyme activities. Proc Soc Exp Biol Med (1988) 0.75
Endothelin stimulates testosterone secretion by rat Leydig cells. J Endocrinol (1993) 0.75
[Role of hypertension in determining valvular diseases in patients with chronic uremia and dialytic treatment]. Cardiologia (1998) 0.75
Congenital complete absence of the pericardium. Minerva Cardioangiol (2015) 0.75
Comparison between three mathematical models of KT/V. Int J Artif Organs (1988) 0.75
[Regional sodium sequestration syndrome in percutaneous nephrolithotomy]. Minerva Anestesiol (1986) 0.75
[The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report]. G Ital Nefrol (2009) 0.75
[Considerations on the hemodialytic treatment of acute renal insufficiency]. Minerva Med (1967) 0.75
Desferrioxamine infusion test. Nephrol Dial Transplant (1987) 0.75
Aspirin inhibition of naloxone-induced luteinizing hormone secretion in man. J Clin Endocrinol Metab (1996) 0.75
Sensitivity, specificity and predictive accuracy of Q wave, QX/QT ratio, QTc interval and ST depression during exercise testing in men with coronary artery disease. Am J Cardiol (1987) 0.75
[Further observations on the ophthalmoscopic picture during chronic renal insufficiency treated with periodic hemodialysis]. Minerva Med (1967) 0.75
[Acute thrombotic occlusions of the internal arteriovenous fistula for hemodialysis. Incidence, etiopathology, 1st results of bloodless therapy with fibrinolytic drugs]. Minerva Nefrol (1981) 0.75
[Control of arterial hypertension with periodic hemodialysis in patients with chronic renal insufficiency]. Minerva Nefrol (1968) 0.75
[Our experience in treatment of chronic kidney diseases with periodic hemodialysis]. Minerva Med (1965) 0.75
[Changes in systemic hemodynamics induced by periodic hemodialytic treatment]. Minerva Nefrol (1971) 0.75
Dynamics of bone aluminum over one year of functioning renal graft. Nephron (1993) 0.75
Role of arachidonate metabolism on the in vitro release of luteinizing hormone and prolactin from the anterior pituitary gland: possible involvement of lipoxygenase pathway. Neuroendocrinology (1986) 0.75
Multicentre comparison of cephacetrile and ampicillin in the treatment of urinary tract infections. Eur J Clin Pharmacol (1974) 0.75
Kinetics of aluminoxamine and feroxamine chelates in dialysis patients. Nephron (1992) 0.75
[Value and limits of radionephrography in the diagnosis of hypertensive conditions, with special reference to hypertension associated with unilateral nephropathy]. Minerva Nefrol (1969) 0.75
Effects of moguisteine, a peripheral nonnarcotic antitussive agent, on airway inflammation in guinea-pigs in vivo. Eur Respir J (1996) 0.75
[Reflections on the electrocardiogram in periodic treatment with the artificial kidney]. Minerva Med (1967) 0.75
[Melatonin/circadian rhythm. Is there a feedback between epiphysis and hypophysis?]. Minerva Endocrinol (2002) 0.75
[Duration and complications of permanent shunts for extracorporeal hemodialysis]. Minerva Med (1967) 0.75
The toxicity of amalgam: a preliminary report. Quintessence Int (1988) 0.75
[Italian results in a quality control program for the determination of lead in blood. EEC directive 312/29-3-1977]. Ann Ist Super Sanita (1983) 0.75
Continuous lipase-catalyzed esterification of soybean fatty acids under ultrasound irradiation. Bioprocess Biosyst Eng (2013) 0.75
Effects of the "vascular factor" on platelet and vascular arachidonic acid metabolism in man. Int J Clin Pharmacol Ther Toxicol (1985) 0.75
Prevention of hepatitis C virus infection in a haemodialysis centre. Nephrol Dial Transplant (1996) 0.75
[Case of pancreatitis due to hyperlipemia complicated by acute renal insufficiency]. G Clin Med (1978) 0.75
[Effect of hypothalamic phospholipids in the incretory activity of the hypophysis]. Minerva Endocrinol (1986) 0.75
[Diffusion of the Australia antigen in some hemodialysis centers, in the personnel of some hospitals, in blood donors and in subjects having contact with acute hepatitis]. G Clin Med (1970) 0.75
Endocrine and metabolic aspects in male senescence. J Endocrinol Invest (1985) 0.75
[Lead in blood and erythrocyte ALA-dehydratase activity in family members of 2 populations exposed to various levels of atmospheric lead pollution]. Med Lav (1979) 0.75
[Selective toxicity of amalgam fillings]. Dent Cadmos (1984) 0.75
[Periodic treatment with the artificial kidney of chronic kidney diseases. Notes on technic]. Minerva Med (1965) 0.75
N-acyl-2-substituted-1,3-thiazolidines, a new class of non-narcotic antitussive agents: studies leading to the discovery of ethyl 2-[(2-methoxyphenoxy)methyl]-beta-oxothiazolidine-3-propanoate. J Med Chem (1995) 0.75
Rate of reproductive involution following either exposure to short days or daily administration of melatonin is faster in inbred than in random-bred female Syrian hamsters. J Endocrinol (1989) 0.75